King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Hamed Alhusaini
Dr. Hamed Alhusaini is a senior Medical Oncology consultant and the Acting Chairman of Medical Oncology in Riyadh, Saudi Arabia, widely recognised for his expertise in gynaecological, genitourinary, and gastrointestinal cancers. An Associate Professor of Medicine and a trusted best medical oncology doctor in India and the Middle East for adult solid tumours, he is also a co-author of the Saudi Arabia breast cancer management consensus.
- Over 20+ years of clinical experience in adult medical oncology.
- Acting Chairman of the Medical Oncology Section at a leading Saudi cancer centre.
- Associate Professor of Medicine at a leading regional medical college.
- Active researcher on ovarian, breast, and colorectal cancer outcomes in the Saudi population.
- Actively sees international patients from the Gulf, Africa, and South Asia.
Qualifications & Credentials
Medical Degrees
- MBBS
Fellowships & Special Training
- Fellowship — Medical Oncology
- Training — Gynaecological, Genitourinary & Gastrointestinal Oncology
Certifications & Accreditations
- Saudi Commission for Health Specialties (SCFHS) Registration
- Member — American Society of Clinical Oncology (ASCO)
- Member — European Society for Medical Oncology (ESMO)
Areas of Expertise
Major Conditions Treated
- Breast Cancer
- Ovarian Cancer
- Endometrial & Cervical Cancer
- Colorectal Cancer
- Gastric & Oesophageal Cancer
- Pancreatic & Hepatobiliary Cancer
- Renal Cell Carcinoma
- Prostate Cancer
- Bladder Cancer
- Soft Tissue Sarcomas
- Rare Tumours (Granulosa Cell Tumour, NUT Carcinoma)
Sub-specialties
- Gynaecological Oncology — Systemic Therapy: Leads chemotherapy, targeted therapy, and PARP-inhibitor regimens for ovarian, endometrial, and cervical cancers — a trusted medical oncology specialist Riyadh, Saudi Arabia for women with BRCA-related malignancies.
- Gastrointestinal Medical Oncology: Expert in multi-line systemic therapy for colorectal, gastric, pancreatic, and hepatobiliary tumours, including triplet chemotherapy and biologics.
- Breast Cancer Systemic Therapy: Provides neoadjuvant, adjuvant, and metastatic breast cancer treatment, including HER2-targeted therapy, antibody-drug conjugates, and endocrine therapy.
Advanced Procedures & Treatments
- Chemotherapy (IV and oral regimens)
- Targeted Therapy (HER2, VEGF, EGFR inhibitors)
- Immunotherapy (Checkpoint Inhibitors)
- PARP Inhibitor Therapy for BRCA-mutated cancers
- Capecitabine Monotherapy for Nasopharyngeal Cancer
- Pazopanib Therapy for Soft Tissue Sarcoma
- Molecular Tumour Profiling & Precision Oncology
- Tumour Board Multidisciplinary Case Review
Professional Experience
Current Affiliation
- King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh, Saudi Arabia — Acting Chairman, Medical Oncology Section, Oncology Centre (Present)
Past Affiliations
- Information not publicly available.
Academic & Research Roles
- Associate Professor — College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
- Faculty — Best of ASCO UAE & KFSHRC CME programmes
- Editorial contributor — Saudi Oncology Society
Key Achievements
- 20+ years of clinical practice in adult medical oncology
- Co-author of the Saudi Arabia Breast Cancer Management Consensus (KFSHRC, 2025)
- Published retrospective cohort studies on ovarian granulosa cell tumour across 30+ years
- Regular speaker at regional and international oncology conferences
- Manages complex, multi-line chemotherapy regimens for international patients
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- American Society of Clinical Oncology (ASCO)
- European Society for Medical Oncology (ESMO)
- Saudi Oncology Society
- Gulf Union Against Cancer
Research & Publications
Published Papers (Selected)
- Alhusaini H, Elshenawy MA, Badran A, et al. Adult-Type Ovarian Granulosa Cell Tumour: Treatment Outcomes From a Single-Institution Experience. Cureus. 2022.
- Al-Moghrabi N, Al-Showimi M, Alqahtani A, Almalik O, Alhusaini H, et al. Constitutional BRCA1 and MGMT Methylation as Risk Factors for Triple-Negative Breast Cancer and High-Grade Serous Ovarian Cancer in Saudi Women. Int J Mol Sci. 2024;25(6):3108.
- Al-Badawi IA, Munkarah AR, Tulbah A, Babic II, Al Husaini H, Ahmad S. A Detailed Study of Patients and Tumor Characteristics of Epithelial Ovarian Cancer. Int J Gynecol Cancer. 2013.
Ongoing Research & Clinical Interests
- Outcomes of BRCA-mutated ovarian cancer in Saudi women
- Triplet chemotherapy with bevacizumab in metastatic colorectal cancer
- Targeted therapy and immunotherapy in rare solid tumours
- Obesity and survival in epithelial gynaecological tumours
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Medical Oncology Consultation | ₹1,500 – ₹3,500 | $18 – $42 |
| Chemotherapy (per cycle, regimen-dependent) | ₹25,000 – ₹1,80,000 | $300 – $2,160 |
| Targeted Therapy (per month, drug-dependent) | ₹60,000 – ₹3,50,000 | $720 – $4,200 |
| Immunotherapy (per cycle) | ₹90,000 – ₹2,80,000 | $1,080 – $3,360 |
| Tumour Marker / Molecular Profiling Panel | ₹8,000 – ₹60,000 | $96 – $720 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Hamed Alhusaini use in Medical Oncology treatment?
Dr. Hamed Alhusaini uses evidence-based systemic therapy platforms including chemotherapy, HER2-targeted therapy, PARP inhibitors, checkpoint-inhibitor immunotherapy, and molecular tumour profiling. For international patients, Cancer Rounds can arrange a virtual pre-travel consultation to review pathology and imaging before arrival.
2. What conditions does Dr. Hamed Alhusaini specialize in treating?
Dr. Hamed Alhusaini specialises in gynaecological cancers (ovarian, endometrial, cervical), breast cancer, colorectal cancer, gastric and pancreatic cancer, and rare solid tumours, and is regarded as a leading medical oncology specialist in Riyadh, Saudi Arabia for best cancer treatment and second opinions.
3. How do I book an appointment with Dr. Hamed Alhusaini?
Appointments with Dr. Hamed Alhusaini can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Hamed Alhusaini?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Hamed Alhusaini, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Hamed Alhusaini offer second opinions for Medical Oncology cases?
Yes. Second opinion consultations with Dr. Hamed Alhusaini can be arranged via Cancer Rounds for patients seeking an expert Medical Oncology review of diagnosis, staging, and treatment options in Riyadh, Saudi Arabia.
